Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Blood (2016) 128 (9): 1234–1245.

https://doi.org/10.1182/blood-2016-03-707141

Published: 2016

Includes: Supplemental data

Journal Articles

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

Blood (2015) 125 (20): 3118–3127.

https://doi.org/10.1182/blood-2014-05-578575

Published: 2015

Includes: Supplemental data

Journal Articles

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Blood (2014) 124 (9): 1473–1480.

https://doi.org/10.1182/blood-2014-04-571091

Published: 2014

Includes: Supplemental data

Journal Articles

Copy Number Abnormalities Of The Interferon Regulatory Factor-4 ( IRF4 ) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas

Rebecca L Boddicker, Ryan A Knudson, Rhett P Ketterling, Law E Mark, Xiaoming Xing, James R Cerhan, MD, PhD, Yanhong Wu, Julie M Cunningham, Stephen M Ansell, M.D.Ph.D., Andrew L. Feldman

Blood (2013) 122 (21): 3016.

https://doi.org/10.1182/blood.V122.21.3016.3016

Published: 2013

Journal Articles

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival

Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD

Blood (2013) 122 (21): 2821.

https://doi.org/10.1182/blood.V122.21.2821.2821

Published: 2013

Journal Articles

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

Blood (2013) 122 (21): 104.

https://doi.org/10.1182/blood.V122.21.104.104

Published: 2013

Journal Articles

ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients

Mrinal M Patnaik, MBBS, Raphael Itzykson, Terra L Lasho, MT, (ASCP), Olivier Kosmider, MD, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Ryan A Knudson, Rhett P Ketterling, Ayalew Tefferi, MD, Eric Solary

Blood (2013) 122 (21): 1510.

https://doi.org/10.1182/blood.V122.21.1510.1510

Published: 2013

Journal Articles

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2 V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Ayalew Tefferi, MD, Christy Finke, BS, Terra L Lasho, MT, (ASCP), Emnet A Wassie, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD

Blood (2013) 122 (21): 4060.

https://doi.org/10.1182/blood.V122.21.4060.4060

Published: 2013

Journal Articles

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

Ayalew Tefferi, MD, Paola Guglielmelli, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Emnet A Wassie, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Alessandro M Vannucchi, MD

Blood (2013) 122 (21): 1587.

https://doi.org/10.1182/blood.V122.21.1587.1587

Published: 2013

Journal Articles

Phenotypic and Prognostic Correlates of Spliceosome Mutations ( SRSF2 , SF3B1 , U2AF35 ) in Chronic Myelomonocytic Leukemia with ≥ 1% Ring Sideroblasts.

Mrinal M. Patnaik, MBBS, MD, Terra L Lasho, MT, (ASCP), Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 2803.

https://doi.org/10.1182/blood.V120.21.2803.2803

Published: 2012

Journal Articles

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Stefan Ehrentraut, Stefan Nagel, PhD, Michaela Scherr, Bjoern Schneider, Hilmar Quentmeier, PhD, Robert Geffers, PhD, Monika Prochorec-Sobieszek, Rhett P Ketterling, MD, Ryan A Knudson, Andrew L. Feldman, MD, Marshall Kadin, Hans G. Drexler, MD, PhD, Roderick AF MacLeod

Blood (2012) 120 (21): 1567.

https://doi.org/10.1182/blood.V120.21.1567.1567

Published: 2012

Journal Articles

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Shaina A Rozell, MD, Biruk Mengistu, M.D., Naseema Gangat, MD, Curtis A. Hanson, MD, Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 1742.

https://doi.org/10.1182/blood.V120.21.1742.1742

Published: 2012

Journal Articles

Survival and Prognosis in World Health Organization Defined Chronic Myelomonocytic Leukemia- A Mayo Clinic Series of 227 Patients

Mrinal M. Patnaik, MBBS, MD, Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 3790.

https://doi.org/10.1182/blood.V120.21.3790.3790

Published: 2012

Journal Articles

Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)

Naseema Gangat, MD, Mrinal M. Patnaik, MBBS, MD, Kebede Begna, MD, Taxiarchis Kourelius, MD, Ryan A Knudson, Rhett P Ketterling, MD, Janice M Hodnefield, MS, MT(ASCP), Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 423.

https://doi.org/10.1182/blood.V120.21.423.423

Published: 2012

Journal Articles

Prognostic Interactions Between SRSF2 , ASXL1 , and IDH Mutations in Primary Myelofibrosis and Determination of Added Value to Cytogenetic Risk Stratification and DIPSS-Plus

Terra L. Lasho, MT, (ASCP), Naseema Gangat, MD, Christy Finke, BS, Rebecca R. Laborde, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Ryan A. Knudson, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 430.

https://doi.org/10.1182/blood.V120.21.430.430

Published: 2012

Journal Articles

Spliceosome Mutations Involving SRSF2 , SF3B1 and U2AF35 in World Health Organization Defined Chronic Myelomonocytic Leukemia; Prevalence, Clinical Correlates and Prognosis

Mrinal M. Patnaik, MBBS, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 1711.

https://doi.org/10.1182/blood.V120.21.1711.1711

Published: 2012

Journal Articles

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

Blood (2012) 120 (11): 2280–2289.

https://doi.org/10.1182/blood-2012-03-419937

Published: 2012

Includes: Supplemental data

Journal Articles

Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blasts

Mrinal M. Patnaik, Curtis A. Hanson, Nanna H. Sulai, Janice M. Hodnefield, Ryan A. Knudson, Rhett P. Ketterling, Terra L. Lasho, Ayalew Tefferi

Blood (2012) 119 (24): 5674–5677.

https://doi.org/10.1182/blood-2012-03-415356

Published: 2012

Includes: Supplemental data

Journal Articles

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

Shaji Kumar, Rafael Fonseca, Rhett P. Ketterling, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Ryan A. Knudson, Alexandra Greenberg, Stephen J. Russell, Steven R. Zeldenrust, John A. Lust, Robert A. Kyle, Leif Bergsagel, S. Vincent Rajkumar

Blood (2012) 119 (9): 2100–2105.

https://doi.org/10.1182/blood-2011-11-390658

Published: 2012

Journal Articles

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

Mrinal M. Patnaik, Terra L. Lasho, Janice M. Hodnefield, Ryan A. Knudson, Rhett P. Ketterling, Guillermo Garcia-Manero, David P. Steensma, Animesh Pardanani, Curtis A. Hanson, Ayalew Tefferi

Blood (2012) 119 (2): 569–572.

https://doi.org/10.1182/blood-2011-09-377994

Published: 2012

Includes: Supplemental data

NARROW

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Copy Number Abnormalities Of The Interferon Regulatory Factor-4 ( IRF4 ) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2 V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

Phenotypic and Prognostic Correlates of Spliceosome Mutations ( SRSF2 , SF3B1 , U2AF35 ) in Chronic Myelomonocytic Leukemia with ≥ 1% Ring Sideroblasts.

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Survival and Prognosis in World Health Organization Defined Chronic Myelomonocytic Leukemia- A Mayo Clinic Series of 227 Patients

Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)

Prognostic Interactions Between SRSF2 , ASXL1 , and IDH Mutations in Primary Myelofibrosis and Determination of Added Value to Cytogenetic Risk Stratification and DIPSS-Plus

Spliceosome Mutations Involving SRSF2 , SF3B1 and U2AF35 in World Health Organization Defined Chronic Myelomonocytic Leukemia; Prevalence, Clinical Correlates and Prognosis

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blasts

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only